Internal Advisory Board

Major User, PI, and Facility Director: Adam Wang, PhD, Assistant Professor

Dr. Wang is an Assistant Professor in the Radiological Sciences Laboratory (RSL) division of the Department of Radiology. Dr. Wang's research on advanced x-ray and CT imaging systems and methods include novel system design, model-based image reconstruction, spectral imaging, and radiation transport methods. His work spans image-guided interventions, image-guided radiotherapy, and diagnostic radiology. Dr. Wang completed his PhD at Stanford in 2012, where he developed methods to maximize the information content of dual energy imaging. He then completed a postdoctoral fellowship at Johns Hopkins University, followed by several years in industry as a Senior Scientist at Varian Medical Systems, prior to returning to Stanford.


Major User, PI-Clinical: Garry Gold, MD, Professor

Dr. Gold is Associate Chair of Research at the Stanford School of Medicine, Department of Radiology. Dr. Gold's research has pioneered the use of rapid MRI techniques to evaluate articular cartilage in osteoarthritis. He is the principal investigator on an NIH R01 to translate these techniques to clinical imaging. Dr. Gold has worked closely with basic scientists in Electrical Engineering, Mechanical Engineering, and at the Lucas Center to advance methods of using imaging to study cartilage biomechanics. Dr. Gold's research is funded by an NIH R01 to use MRI to evaluate patellofemoral pain. Dr. Gold is also Principle Investigator of the Stanford/General Electric Healthcare MRI collaboration, which is a project involving multiple investigators and research areas.


Internal Advisory Board Member: Lawrence "Rusty" Hofmann, MD, Professor

Dr. Hofmann is an Associate Professor of Radiology and Chief of lnterventional Radiology in the Department of Radiology at Stanford University. Dr. Hofmann is also an adjunct faculty member in Radiology at Johns Hopkins University. He is an expert in treating patients with peripheral vascular disease with endovascular therapies. He runs the Interventional Radiology Translational Therapies laboratory in the Molecular Imaging Program. The purpose of the lab is to develop minimally invasive, highly targeted alternatives for tumor treatment, vascular incompetence and tissue transplant, as well as to improve MR detection of tumors, using multimodal imaging for Interventional Radiology. Primary models currently use gene therapy for hepatocarcinoma (HCC) in rats, HIFU for hindlimb ischemia in rabbits, and engrafting cell infusion for liver challenged mice.


Internal Advisory Board Member: Kim Butts Pauly, PhD, Professor

Internal Advisory Board Member: Kim Butts Pauly, Ph.D. is Professor of Radiology, and, by courtesy, of Bioengineering. She directs the interventional MRI program in the Department of Radiology and has 20 years of experience with MRI and pulse sequence programming. She has authored/coauthored 70 peer-reviewed articles, including novel methods for MR thermometry of frozen and heated tissue. In addition, she was involved with the fully integrated X-ray and MRI system, including the development of x-ray compatible MR coils.


Internal Advisory board member: Nishita Kothary, MD, Professor

Dr. Kothary is an Associate Professor of Radiology at the Stanford University Medical Center. Dr. Kothary’s clinical and research interests are in Interventional Oncology, specifically for primary and secondary liver cancer.  Her research interests lie in early diagnosis, Radiogenomics and the use of advanced imaging in the diagnosis and treatment of hepatocellular carcinoma. Dr. Kothary is an active member of the Zeego Lab, with interest in new cone beam CT applications for perfusion imaging and dual phase imaging of the liver. 


Internal Advisory board member: Jeremy Heit, MD, PhD, Assistant Professor

Dr. Heit is a neurointerventional radiologist who specializes in treating stroke, brain aneurysms, brain arteriovenous malformations, brain and spinal dural arteriovenous fistulae, carotid artery stenosis, vertebral body compression fractures, and congenital vascular malformations. Dr. Heit treats all of these conditions using minimally-invasive, image-guided procedures and state-of-the-art technology. Dr. Heit is developing novel imaging techniques for the evaluation of patients with ischemic cerebrovascular disease, including stroke, and vasospasm. He is working with the Zeego Lab Team to develop panel perfusion imaging for rapid triage of patients with acute ischemic stroke and cerebral vasospasm.


Former Director: Rebecca Fahrig, PhD

Dr. Fahrig, was a Professor in the Department of Radiology at Stanford University and led the Zeego Lab until 2015. Dr. Fahrig has extensive experience with digital flat panels, and is an expert in the design, characterization and implementation of novel 3D imaging systems for diagnostic and image-guided procedures. Dr. Fahrig earned her Ph.D. at the University of Western Ontario in 1999, where she worked on the development of a C-arm-based imaging system for 3D conebeam CT angiography; her work in the area of C-arm imaging is now optimization of flat-panel based C-arm imaging, with work in the area of conebeam reconstruction, image correction, and protocol optimization.